scispace - formally typeset
Q

Qiuhong Duan

Researcher at Huazhong University of Science and Technology

Publications -  8
Citations -  4326

Qiuhong Duan is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & Cancer research. The author has an hindex of 1, co-authored 1 publications receiving 3426 citations.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The role of branched chain amino acids metabolic disorders in tumorigenesis and progression.

TL;DR: In this paper , a review of the role of BCAAs metabolic disorders in different tumor types by focusing on the impacts of metabolic disorders of BAAs and discussing the notable proteins involved in cancer metabolic reprogramming of BAUs, such as BCAT1/2, BCKDH-BCKDK-PPM1K complex, transporters of BAIs and its metabolites, transcription factors and so on, and present several possible diagnose approaches and therapies to BAAs-related cancers.
Journal ArticleDOI

BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway

TL;DR: It is demonstrated that BCKDK promotes OC proliferation and migration by activating the MEK/ERK signaling pathway and targeting the BCK DK-MEK axis may provide a new therapeutic strategy for treating patients with OC.
Journal ArticleDOI

The role of T-LAK cell-originated protein kinase in targeted cancer therapy

TL;DR: The role of TOPK in targeted cancer therapy was concluded, its tumor-related signaling network and known TOPK inhibitors were summarized, and future research directions for TOPK were assessed.
Journal ArticleDOI

Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC

TL;DR: In this paper , the combination of alectinib and HI-032 (a TOPK inhibitor) suppressed the growth and promoted the apoptosis of ALK-positive NSCLC cells ex vivo and in vivo.